Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Should the symptomatic region be included in dissemination in space in MRI criteria for MS?
Ex vivo expanded regulatory T cells CD4(+)CD25(+)FoxP3(+)CD127(Low) develop strong immunosuppressive activity in patients with remitting-relapsing multiple sclerosis.
A Review of Possible Herbal Treatment in Multiple Sclerosis in Traditional Persian Medicine.
Protein kinase CK2 governs the molecular decision between encephalitogenic TH17 cell and Treg cell development.
SYSTEMIC TRANSPLANTATION OF BONE MARROW MONONUCLEAR CELLS PROMOTES AXONAL REGENERATION AND ANALGESIA IN A MODEL OF WALLERIAN DEGENERATION.
Fixing the jugular flow reduces ventricle volume and improves brain perfusion.
Ds-HMGB1 and fr-HMGB induce depressive behavior through neuroinflammation in contrast to nonoxid-HMGB1.
Comparison of Personal Resources in Patients Who Differently Estimate the Impact of Multiple Sclerosis.
Identification of Tricyclic Agonists of Sphingosine-1-Phosphate Receptor 1 (S1P1) Employing Ligand-Based Drug Design.
Intraneural injection of a test dose of local anesthetic in peripheral nerves - does it induce histological changes in nerve tissue?
Dilated perivascular spaces and fatigue: is there a link? Magnetic resonance retrospective 3Tesla study.
Optic neuritis in multiple sclerosis: Looking from a patient's eyes.
Role of chondroitin sulfate (CS) modification in the regulation of protein tyrosine receptor type Z (PTPRZ) activity: pleiotrophin-PTPRZ-A signaling is involved in oligodendrocyte differentiation.
Normalization of sonographical multifocal nerve enlargements in a MADSAM patient following a good clinical response to intravenous immunoglobulin.
Fingolimod: A Disease-Modifier Drug in a Mouse Model of Amyotrophic Lateral Sclerosis.
Resveratrol Defends Blood-brain Barrier Integrity in Experimental Autoimmune Encephalomyelitis Mice.
Guillain Barré Syndrome, Systemic Lupus Erythematosus and Acute Intermittent Porphyria - A Deadly Trio.
Longitudinal changes of cerebral glutathione (GSH) levels associated with the clinical course of disease progression in patients with secondary progressive multiple sclerosis.
Fully-integrated framework for the segmentation and registration of the spinal cord white and gray matter.
The Changing Landscape of Childhood Inflammatory Central Nervous System Disorders.
Exploring the methods of data analysis in multifocal visual evoked potentials.
Antibodies in multiple sclerosis oligoclonal bands target debris.
Anconeus Epitrochlearis Muscle Causing Ulnar Neuropathy at the Elbow: Clinical and Neurophysiological Differential Diagnosis.
Brain Atrophy as a Measure of Neuroprotective Drug Effects in Multiple Sclerosis: Influence of Inflammation.
Leptin inhibitors from fungal endophytes (LIFEs): Will be novel therapeutic drugs for obesity and its associated immune mediated diseases.
Pages
« first
‹ previous
…
792
793
794
795
796
797
798
799
800
…
next ›
last »